Clinical trial registry record

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 10, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06619405
Last registry update
August 10, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Duke University
Enrollment
100
Countries
United States
Match confidence
62%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · SINGLE GROUP · DIAGNOSTIC · NONE
Evidence population
Human clinical study registration
Participants
100
Population
ALL · 50 Years to 89 Years
Duration
2025-08-15 to 2028-01-31
Intervention
Streetlab VR
Comparator
Not reported
Outcomes measured
Total number of participants with total ellipsoid zone (EZ) band attenuation — Approximately 2 years; Total number of participants with partial ellipsoid zone (EZ) band attenuation — Approximately 2 years; Rod-mediated dark adaptation — Single visit, approximately 5-6 hours; Reading performance as measured by the MNREAD (Minnesota low vision reading) chart — Single visit, approximately 5-6 ho…; Mobility as measured by the Mobility Standardized Test (MOST) — Single visit, approximately 5-6 hours
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 62% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 62%Source terminology contains: age-related macular degeneration. Abstract supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON